ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Interest expense on outstanding debt
5Y CAGR
+145.7%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
89.6x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.60M | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | -100.0% |
| 2021 | $106000.00 | +265.5% |
| 2020 | $29000.00 | - |
| 2018 | $0.00 | - |